RARE NASDAQ
Ultragenyx Pharmaceutical Inc.
1W: +5.0%
1M: -42.6%
3M: -54.8%
YTD: -35.5%
1Y: -49.2%
3Y: -58.8%
5Y: -84.0%
$15.22
+0.47 (+3.19%)
Weekly Expected Move ±9.7%
$12
$14
$15
$17
$18
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$717M
Revenue
+17.5% YoY
$-586M
Net Income
-10.0% YoY
$-489M
Free Cash Flow
-14.5% YoY
84.1%
Gross Margin
-35.0%
Op. Margin
-43.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE839.4%
ROA-45.6%
ROIC-67.5%
Valuation
P/E-2.6
P/B-5.3
EV/EBITDA-9.1
Leverage
Debt/Equity-4.13
Current Ratio1.73
Interest Cov.-6.7x
Quality Scores
Piotroski F2/9
Altman Z-4.52
Beneish M-2.20